Results 41 to 50 of about 183,117 (350)

Cementoplasty of bone metastases

Diagnostic and Interventional Imaging, 2012
Cementoplasty is a palliative treatment for bone metastases. It can be performed alone or in addition to other treatments, such as radiotherapy, radiofrequency ablation or cryotherapy. It is usually performed to reduce pain where the metastases involve the spine and pelvis.
Deschamps, F., de Baere, T.
openaire   +2 more sources

Research progress of bone metastases: From disease recognition to clinical practice

Frontiers in Oncology, 2023
Bone metastases, as one of the common types of metastatic tumors, have a great impact on the survival period and quality of life of patients. Bone metastases are usually characterized by bone destruction.
Wenbo Yang, Qing Pan, Fuhua Huang, Hongzhi Hu, Zengwu Shao   +4 more
doaj   +1 more source

Value of procollagen type I aminoterminal propeptide in women with breast cancer with regard to metastases

, 2011
Background. The aim of this study was to show the importance of the bone marker procollagen type 1 aminoterminal propeptide (P1NP) in detecting bone metastases in women suffering from breast cancer.
Oremek, Gerhard, G. M. Oremek, Clouth, Aline, A. Clouth   +3 more
core   +1 more source

Characterization of tenascin-W, an emerging player in the metastatic bone marrow niche [PDF]

, 2015
Tumors are heterogeneous organ-like tissues including not only tumor cells themselves but also auxiliary cells such as, endothelial cells, fibroblasts, inflammatory cells, and bone marrow derived stem or stromal cells (BMSCs), which collectively create ...
Chiovaro, Francesca
core   +1 more source

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice

, 2022
Immunotherapies use components of the immune system, such as T cells, to fight cancer cells, and are changing cancer treatment, causing durable responses in some patients.
Felipe Olvera, Patricia Juárez, Andrea Verdugo‐Meza, Olvera, Felipe, Samanta Jiménez, Florian Drescher, Drescher, Florian, Bennett D. Elzey, Pierrick G.J. Fournier, Danna L. Arellano, Almeida-Luna, Paloma S., Elzey, Bennett D., Verdugo‐Meza, Andrea, Corral-Avila, Juan A., Corral‐Avila, Juan A., Guise, Theresa A., Paloma S. Almeida‐Luna, Arellano, Danna L., Almeida‐Luna, Paloma S., Jiménez, Samanta, Fournier, Pierrick G.J., Juan A. Corral‐Avila, Juárez, Patricia, Theresa A. Guise, Verdugo-Meza, Andrea   +24 more
core   +1 more source

Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants. [PDF]

PLoS ONE, 2013
BACKGROUND: Intra-tumoral steroidogenesis and constitutive androgen receptor (AR) activity have been associated with castration-resistant prostate cancer (CRPC).
Emma Jernberg, Elin Thysell, Erik Bovinder Ylitalo, Stina Rudolfsson, Sead Crnalic, Anders Widmark, Anders Bergh, Pernilla Wikström   +7 more
doaj   +1 more source

PECAM1 plays a role in the pathogenesis and treatment of bone metastases

Frontiers in Genetics, 2023
Bone is the third most common metastatic site for all primary tumors, the common primary focus of bone metastases include breast cancer, prostate cancer, and so on.
Zhuo-Tao Liang, Zhuo-Tao Liang, Jia-Ke Li, Jiong Li, Jiong Li, Hao Tang, Hao Tang, Chao-Feng Guo, Chao-Feng Guo, Hong-Qi Zhang, Hong-Qi Zhang   +10 more
doaj   +1 more source

Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer

Journal of International Medical Research, 2020
Objective To investigate the clinical features and evaluate the prognostic factors in patients with bone metastases from non-small cell lung cancer (NSCLC). Methods We retrospectively investigated 356 patients with NSCLC with bone metastases from January
Xiao-Tian Wu, Jian-Wei Zhou, Long-Ci Pan, Ting Ge   +3 more
doaj   +1 more source

Incidence and gender difference of brain metastases in newly diagnosed follicular thyroid cancer patients

European Thyroid Journal
Background: Population-based estimates of brain metastases in follicular thyroid cancer (FTC) patients with or without distant metastases (DMs) at diagnosis are lacking.
Ruiguo Zhang, Weijian Li, Hui Wang, Wenxin Zhang, Jinyan Chai, Pengpeng Chang, Qiang Jia, Wei Zheng   +7 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source